Patents by Inventor Mark W. Kroll

Mark W. Kroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9480851
    Abstract: A multi-modal electrotherapy apparatus including circuitry for administering defibrillation therapy and for administering medium voltage therapy (MVT). A combined-use capacitor bank of at least one capacitor stores energy to be administered as defibrillation therapy and MVT. Combined-use discharge circuitry electrically is coupled between the combined-use capacitor bank and patient terminals for selectively administering energy from the capacitor bank according to a plurality of controllable waveforms as either defibrillation therapy or MVT. A controller is configured to cause the discharge circuitry to apply the MVT from the capacitor bank while the capacitor bank undergoes charging in preparation for administration of the defibrillation therapy.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: November 1, 2016
    Assignee: Galvani, Ltd.
    Inventor: Mark W. Kroll
  • Publication number: 20160271390
    Abstract: The present invention relates, generally, to scientific and medical system methods for diagnosis of implantable cardioverter defibrillator (ICD) lead conductor anomalies, in particular conductor migration and externalization within an ICD implantable cardiac lead. The method uses an “imaginary” component of the high frequency transmission line impedance having certain spectral changes that correspond to movements of the conductor or an “imaginary impedance”. This allows the detection of conductor migration and small insulation failures.
    Type: Application
    Filed: March 24, 2016
    Publication date: September 22, 2016
    Inventors: Mark W. Kroll, Charles D. Swerdlow
  • Publication number: 20160250462
    Abstract: The invention relates to a method and apparatus for diagnosis of conductor anomalies, such as insulation failures, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD), a pacemaker, or a neurostimulator. Insulation failures are detected and localized by identifying changes in electrical fields via surface (skin) potentials. Small variations in potential are detected along the course of the electrode near the site of insulation failure.
    Type: Application
    Filed: February 26, 2016
    Publication date: September 1, 2016
    Inventors: Mark W. Kroll, Charles D. Swerdlow
  • Patent number: 9427577
    Abstract: Disclosed is a method for the diagnosis of conductor anomalies, such as an insulation failure resulting in a short circuit, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD). Upon determining if a specific defibrillation pathway is shorted, the method excludes the one electrode from the defibrillation circuit, delivering defibrillation current only between functioning defibrillation electrodes. Protection can be provided against a short in the right-ventricular coil-CAN defibrillation pathway of a pectoral, transvenous ICD with a dual-coil defibrillation lead. If a short caused by an in-pocket abrasion is present, the CAN is excluded from the defibrillation circuit, delivering defibrillation current only between the right-ventricular and superior vena cava defibrillation coils. Determination that the defibrillation pathway is shorted may be made by conventional low current measurements or delivery of high current extremely short test pulses.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: August 30, 2016
    Assignee: Lambda Nu Technology LLC
    Inventors: Mark W. Kroll, Charles D. Swerdlow
  • Patent number: 9408638
    Abstract: A spinal correction system for implantation in a patient, the system including a reciprocating adjuster and/or a resistance adjuster coupled to a stabilizing member, for example. The resistance adjuster includes a potential energy drive, a slide unit, and a resistance unit. The reciprocating adjuster includes a piston unit, a transfer unit coupled to the piston unit, and a return mechanism.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: August 9, 2016
    Assignee: K2M, Inc.
    Inventors: Ryan M. Kroll, Steven J. Seme, Thomas J. Gisel, Mark W. Kroll
  • Publication number: 20160220276
    Abstract: A spinal correction system for implantation in a patient, the system including a reciprocating adjuster and/or a resistance adjuster coupled to a stabilizing member, for example. The resistance adjuster includes a potential energy drive, a slide unit, and a resistance unit. The reciprocating adjuster includes a piston unit, a transfer unit coupled to the piston unit, and a return mechanism.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Inventors: Ryan M. Kroll, Steven J. Seme, Thomas J. Gisel, Mark W. Kroll
  • Publication number: 20160206885
    Abstract: Apparatus and method for treating an arrhythmia in a patient using an electrotherapy device such as a subcutaneous pacing device. The device applies a series of electrotherapy pulses in response to the presence of the arrhythmia. Various provisions are disclosed for mitigating pain or discomfort as a result of the electrotherapy pulses.
    Type: Application
    Filed: October 26, 2015
    Publication date: July 21, 2016
    Inventors: Byron L. Gilman, Mark W. Kroll
  • Publication number: 20160143669
    Abstract: A spinal correction system for implantation in a patient, the system including a reciprocating adjuster and/or a resistance adjuster coupled to a stabilizing member, for example. The resistance adjuster includes a potential energy drive, a slide unit, and a resistance unit. The reciprocating adjuster includes a piston unit, a transfer unit coupled to the piston unit, and a return mechanism.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 26, 2016
    Inventors: Ryan M. Kroll, Steven J. Seme, Thomas J. Gisel, Mark W. Kroll
  • Patent number: 9333009
    Abstract: A spinal correction system for implantation in a patient, the system including a reciprocating adjuster and/or a resistance adjuster coupled to a stabilizing member, for example. The resistance adjuster includes a potential energy drive, a slide unit, and a resistance unit. The reciprocating adjuster includes a piston unit, a transfer unit coupled to the piston unit, and a return mechanism.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: May 10, 2016
    Assignee: K2M, Inc.
    Inventors: Ryan M. Kroll, Steven J. Seme, Thomas J. Gisel, Mark W. Kroll
  • Publication number: 20160095994
    Abstract: A breathing apparatus includes a breathing mask, hose, and first housing in fluid communication with the hose and breathing mask. The first housing has first and second chambers which are separated by a barrier comprising a carbon dioxide scrubber. The breathing apparatus is configured to conduct hypoxic therapy and tailor the therapeutic session to the patient while collecting data about patient response.
    Type: Application
    Filed: October 1, 2014
    Publication date: April 7, 2016
    Applicant: THIRD WIND, LLC
    Inventors: Jarrod D. Currin, Byron L. Gilman, Mark W. Kroll
  • Publication number: 20160082275
    Abstract: Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (MVT) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of MVT parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of MVT. Administration of MVT is automatically and dynamically adjusted to achieve specific treatment or life-support objectives, such as prolongation of the body's ability to endure and respond to MVT, specifically addressing the type of arrhythmia or other pathologic state of the patient with targeted treatment, a tiered-intensity MVT treatment strategy, and supporting patients in non life-critical conditions where the heart may nevertheless benefit from a certain level of assistance.
    Type: Application
    Filed: September 28, 2015
    Publication date: March 24, 2016
    Inventors: Byron L. Gilman, Mark W. Kroll, James E. Brewer
  • Patent number: 9168381
    Abstract: Apparatus and method for treating an arrhythmia in a patient using an electrotherapy device. The device applies a series of electrotherapy pulses in response to the presence of the arrhythmia. In one aspect, indicia of movement by the patient is sensed, and an inference is made whether the movement is an evoked response to the administration of the electrotherapy pulses. Application of subsequent electrotherapy pulses is adjusted in response to an inference of the evoked response constituting discomfort of the patient.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: October 27, 2015
    Assignee: Galvani, Ltd.
    Inventors: Byron L. Gilman, Mark W. Kroll
  • Publication number: 20150273225
    Abstract: Active surveillance of potential lead anomalies in implanted medical leads utilizes test signal(s) delivered through an output current pathway and induced signals monitored via an independent monitor current pathway to detect for any reactions to the test signals in the induced signals. Various specific responses can be initiated if a potential insulation breach or anomaly in the implanted medical lead is identified due to detection of a “positive” test result in the induced signals on the monitor current pathway in reaction to a test signal applied to the output current pathway.
    Type: Application
    Filed: March 25, 2014
    Publication date: October 1, 2015
    Applicant: Lamda Nu, LLC
    Inventors: Charles D. Swerdlow, Mark W. Kroll
  • Patent number: 9144684
    Abstract: Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (MVT) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of MVT parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of MVT. Administration of MVT is automatically and dynamically adjusted to achieve specific treatment or life-support objectives, such as prolongation of the body's ability to endure and respond to MVT, specifically addressing the type of arrhythmia or other pathologic state of the patient with targeted treatment, a tiered-intensity MVT treatment strategy, and supporting patients in non life-critical conditions where the heart may nevertheless benefit from a certain level of assistance.
    Type: Grant
    Filed: July 22, 2014
    Date of Patent: September 29, 2015
    Assignee: Galvani, Ltd.
    Inventors: Byron L. Gilman, Mark W. Kroll, James E. Brewer
  • Publication number: 20150151118
    Abstract: Disclosed is a method for the diagnosis of conductor anomalies, such as an insulation failure resulting in a short circuit, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD). Upon determining if a specific defibrillation pathway is shorted, the method excludes the one electrode from the defibrillation circuit, delivering defibrillation current only between functioning defibrillation electrodes. Protection can be provided against a short in the right-ventricular coil-CAN defibrillation pathway of a pectoral, transvenous ICD with a dual-coil defibrillation lead. If a short caused by an in-pocket abrasion is present, the CAN is excluded from the defibrillation circuit, delivering defibrillation current only between the right-ventricular and superior vena cava defibrillation coils. Determination that the defibrillation pathway is shorted may be made by conventional low current measurements or delivery of high current extremely short test pulses.
    Type: Application
    Filed: August 7, 2014
    Publication date: June 4, 2015
    Inventors: Mark W. Kroll, Charles D. Swerdlow
  • Publication number: 20150032170
    Abstract: Apparatus and method for treating an arrhythmia in a patient using an electrotherapy device such as a subcutaneous pacing device. The device applies a series of electrotherapy pulses in response to the presence of the arrhythmia. Various provisions are disclosed for mitigating pain or discomfort as a result of the electrotherapy pulses.
    Type: Application
    Filed: July 30, 2014
    Publication date: January 29, 2015
    Inventors: Byron L. Gilman, Mark W. Kroll
  • Publication number: 20140336718
    Abstract: Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (MVT) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of MVT parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of MVT. Administration of MVT is automatically and dynamically adjusted to achieve specific treatment or life-support objectives, such as prolongation of the body's ability to endure and respond to MVT, specifically addressing the type of arrhythmia or other pathologic state of the patient with targeted treatment, a tiered-intensity MVT treatment strategy, and supporting patients in non life-critical conditions where the heart may nevertheless benefit from a certain level of assistance.
    Type: Application
    Filed: July 22, 2014
    Publication date: November 13, 2014
    Inventors: Byron L. Gilman, Mark W. Kroll, James E. Brewer
  • Publication number: 20140324123
    Abstract: Method and apparatus for diagnosis of conductor anomalies, such as partial conductor failures, in an implantable lead for an implantable medical device are disclosed. In various embodiments, small changes in the lead impedance are identified by the use of a small circuit element that is incorporated as part of the distal end of the implantable lead. In various embodiments, the small circuit element is electrically connected to a lead conductor and/or electrode of the implantable lead. Methods of diagnosing conductor anomalies in accordance with these embodiments generate measured values that depend only on the impedance of the conductors and electrodes of the lead, and not on the behavior of the conductor-tissue interface and other body tissues.
    Type: Application
    Filed: March 25, 2014
    Publication date: October 30, 2014
    Inventors: Mark W. Kroll, Charles D. Swerdlow
  • Patent number: 8868178
    Abstract: Apparatus and method for treating an arrhythmia in a patient using an electrotherapy device such as a subcutaneous pacing device. The device applies a series of electrotherapy pulses in response to the presence of the arrhythmia. Various provisions are disclosed for mitigating pain or discomfort as a result of the electrotherapy pulses.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: October 21, 2014
    Assignee: Galvani, Ltd.
    Inventors: Byron L. Gilman, Mark W. Kroll
  • Patent number: 8868186
    Abstract: An exemplary method includes introducing current between a first pair of electrodes configured for placement internally in a patient, triggering a potential measurement between a second pair of electrodes configured for placement internally in a patient wherein communication of a signal through the patient allows for proper triggering, measuring potential between the second pair of electrodes and, based at least in part on the measuring and the introducing, determining a cardiac condition. Other exemplary methods, devices, systems, etc., are also disclosed.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: October 21, 2014
    Assignee: Pacesetter, Inc.
    Inventor: Mark W. Kroll